Effects of Corticosteroids on Expression of Interleukin-18 in the Airway Mucosa of a Mouse Model of Allergic Rhinitis

Abstract

Objectives:

In this study, we aimed to investigate the release and response of interleukin (IL)-18 to steroid treatment in a mouse model of allergic rhinitis.

Methods:

BALB/c mice were sensitized systemically by intraperitoneal injection of ovalbumin and locally by ovalbumin inhalation. Dexamethasone sodium phosphate was given by intraperitoneal injection in the steroid treatment group. Symptom scores, eosinophil counts, and IL-18 concentrations in the nasal and lung lavage fluids were analyzed.

Results:

The symptom scores and eosinophil counts of the negative control and steroid treatment groups were significantly lower than those of the positive control group (p < .01). The mean IL-18 concentrations in the nasal lavage fluid were not significantly different among the three groups (56.68 ± 9.57, 63.39 ± 8.93, and 64.47 ± 6.83 pg/mL, respectively). The IL-18 concentrations in the lung lavage fluid were significantly different between the positive control group and the steroid treatment group (430.75 ± 154.54 and 69.94 ± 14.26 pg/mL, respectively, p = .028).

Conclusions:

The IL-18 concentration was found to be increased in the lung lavage fluid, but not in the nasal lavage fluid, in a mouse model of allergic rhinitis. Increased IL-18 concentrations returned toward the previous concentrations after steroid treatment. These results suggest that the roles of IL-18 may be different in the pathogenesis of allergic rhinitis and the pathogenesis of asthma.

Keywords

allergic rhinitis glucocorticoid interleukin-18 nasal secretion respiratory mucosa

Get full access to this article

View all access options for this article.

References

Rudack

Bachert

. Glucocorticosteroids rapidly inhibit allergen-induced expression of E-selectin in vitro in a mucosal model of allergic rhinitis. Allergy 2000;55:363–8.

Fantuzzi

Dinarello

. Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999;19:1–11.

Okamura

Tsutsui

Kashiwamura

Yoshimoto

Nakanishi

. Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998;70:281–312.

Okamura

Kashiwamura

Tsutsui

Yoshimoto

Nakanishi

. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 1998;10:259–64.

Trajkovic

Hunter

. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol 2000;30:3147–56.

Nakanishi

Yoshimoto

Tsutsui

Okamura

. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423–74.

Hoshino

Wiltrout

Young

. IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response. J Immunol 1999;162:5070–7.

Netea

Kullberg

Verschueren

Van Der Meer

. Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000;30:3057–60.

Wild

Sigounas

Sur

. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000;164:2701–10.

10.

Verhaeghe

Gevaert

Holtappels

. Up-regulation of IL-18 in allergic rhinitis. Allergy 2002;57:825–30.

11.

Davis

Denison

Wood

Greening

. Reduced interleukin-18 levels in BAL specimens from patients with asthma compared to patients with sarcoidosis and healthy control subjects. Chest 2002;121:1421–6.

12.

Wong

. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177–83.

13.

Chang

Segal

Nakanishi

Okamura

Shevach

. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 2000;30:1113–9.

14.

Tanaka

Miyazaki

Oashi

. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001;107:331–6.

15.

Yoshizawa

Nomaguchi

Izaki

Kitamura

. Serum cytokine levels in atopic dermatitis. Clin Exp Dermatol 2002;27:225–9.

16.

Johansson

Hourihane

Bousquet

; European Academy of Allergology and Clinical Immunology nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813–24. [Erratum in Allergy 2001;56:1229.]

17.

Bousquet

Van Cauwenberge

Khaltaev

; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108 (suppl 5):S147–S334.

18.

Wang

Clement

Smitz

De Waele

Derde

. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995;106:278–85.

19.

Bachert

Hauser

Prem

Rudack

Ganzer

. Pro-inflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1995;252 (suppl 1):S44–S49.

20.

Baraniuk

. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99:S763–S772.

21.

Bentley

Jacobson

Cumberworth

. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877–83.

22.

Holt

Macaubas

Prescott

Sly

. Primary sensitization to inhalant allergens. Am J Respir Crit Care Med 2000;162 (suppl):S91–S94.

23.

Hofstra

Van Ark

Hofman

Kool

Nijkamp

Van Oosterhout

. Prevention of Th2-like cell responses by co-administration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 1998;161:5054–60.

24.

El-Mezzein

Matsumoto

Nomiyama

Miike

. Increased secretion of IL-18 in vitro by peripheral blood mono-nuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001;126:193–8.